General Information of the Compound
Compound ID
CP0096174
Compound Name
AZD-1775
    Show/Hide
Synonyms
1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one
2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one
955365-80-7
AK-99219
AZD 1775
AZD-1775
AZD1775
Adavosertib
K2T6HJX3I3
MK 1775
MK-1775
MK1775
UNII-K2T6HJX3I3
    Show/Hide
Structure
Formula
C27H32N8O2
Molecular Weight
500.607
Canonical SMILES
CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1
    Show/Hide
InChI
InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)
    Show/Hide
InChIKey
BKWJAKQVGHWELA-UHFFFAOYSA-N
CAS
955365-80-7
Physicochemical Property
logP
2.886
Rotatable Bonds
7
Heavy Atom Count
37
Polar Areas
104.34
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
10
Complexity
37

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24856436
SID: 50087297
ChEMBL ID
CHEMBL1976040
DrugBank ID
DB11740
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01427, Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 4940 nM
   TI
   LI
   LO
   TS
2
Ki = 470 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Kd = 324 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 290 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( MK-1775 )
Drug Name MK-1775
Company Merck
Indication
Ovarian cancer
Phase 2
Solid tumour/cancer
Phase 1
Target(s)
Wee1-like protein kinase (WEE1)
Inhibitor